Ep170: David Schenkein on Investing in the Future of Biotech
The Long Run with Luke Timmerman
00:00
Transitioning from CEO to Venture Capitalist in Biotech
This chapter explores the transition of a former healthcare CEO to a venture capitalist, detailing their successful track record in biotech. The discussion highlights their motivations for joining GV and their aspirations to make a significant impact in science and medicine.
Transcript
Play full episode
